ArticleFrontiers in immunology2021

An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells.

James Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.